Wearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Worldwide, the number of people affected by diabetes is rapidly increasing due to aging populations and sedentary lifestyles, with the prospect of exceeding 500 million cases in 2030, resulting in one of the most challenging socio-health emergencies of the third millennium. Daily management of diabetes by patients relies on the capability of correctly measuring glucose concentration levels in the blood by using suitable sensors. In recent years, glucose monitoring has been revolutionized by the development of Continuous Glucose Monitoring (CGM) sensors, wearable non/minimally-invasive devices that measure glucose concentration by exploiting different physical principles, e.g., glucose-oxidase, fluorescence, or skin dielectric properties, and provide real-time measurements every 1–5 min. CGM opened new challenges in different disciplines, e.g., medicine, physics, electronics, chemistry, ergonomics, data/signal processing, and software development to mention but a few. This paper first makes an overview of wearable CGM sensor technologies, covering both commercial devices and research prototypes. Then, the role of CGM in the actual evolution of decision support systems for diabetes therapy is discussed. Finally, the paper presents new possible horizons for wearable CGM sensor applications and perspectives in terms of big data analytics for personalized and proactive medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Electrochemical Glucose Biosensors
Wang, J. (2008) · Chemical Reviews · doi:10.1021/cr068123a · Cited by 3,498 · cited 3×
“SMBG systems are portable devices that allow for the measuring of BG concentration, usually 3–4 times per day, on a drop of capillary blood by means of the oxidation of glucose to gluconolactone catalyzed by glucose oxidase [8].”
MethodInfluential2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Machine learning and data mining methods in diabetes research
Kavakiotis, I., Tsave, O., Salifoglou, A., Maglaveras, N., Vlahavas, I., & Chouvarda, I. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.12.005 · Cited by 1,445
Prevention and management of type 2 diabetes: dietary components and nutritional strategies
Ley, S. H., Hamdy, O., Mohan, V., & Hu, F. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60613-9 · Cited by 1,301
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254
Increasing Prevalence of Gestational Diabetes Mellitus
Ferrara, A. (2007) · Diabetes Care · doi:10.2337/dc07-s206 · Cited by 1,171
Glucose Biosensors: An Overview of Use in Clinical Practice
Yoo, E.-H., & Lee, S.-Y. (2010) · Sensors · doi:10.3390/s100504558 · Cited by 1,137
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 3×
“4% [42] 14-day lifetime, trend arrows, communication with a smart device To read glucose values the sensor needs to be scanned with the receiver or the smartphone, not FDA approved yet”
BackgroundInfluential
Cited by
Electrochemical glucose sensors in diabetes management: an updated review (2010–2020)
Teymourian, H., Barfidokht, A., & Wang, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00304b · Cited by 881
Cappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0121 · Cited by 477
Wearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review
Saha, T., Del Caño, R., Mahato, K., De la Paz, E., Chen, C., Ding, S., Yin, L., & Wang, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00078 · Cited by 442
In Vitro and In Vivo SERS Biosensing for Disease Diagnosis
Moore, T. J., Moody, A. S., Payne, T. D., Sarabia, G. M., Daniel, A. R., & Sharma, B. (2018) · Biosensors · doi:10.3390/bios8020046 · Cited by 161
The Role of Wearable Devices in Chronic Disease Monitoring and Patient Care: A Comprehensive Review
Jafleh, E. A., Alnaqbi, F. A., Almaeeni, H. A., Faqeeh, S., Alzaabi, M. A., & Al Zaman, K. (2024) · Cureus · doi:10.7759/cureus.68921 · Cited by 125
“These improvements have been crucial in reducing the rate of false alarms and enhancing the reliability of glucose monitoring, which is essential for effective diabetes management and patient safety [176].”
Continuous glucose monitoring: Current use in diabetes management and possible future applications
Vettoretti, M., Cappon, G., Acciaroli, G., Facchinetti, A., & Sparacino, G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818774078 · Cited by 96
“Glucose monitoring in diabetes therapy has been revolutionized by the introduction of continuous glucose monitoring (CGM) sensors.(1-4) Most of the CGM sensors currently on the market are minimally invasive systems that measure glucose concentrations in the subcutis by a needle electrochemical sensor, but other system…”
BackgroundRecent Advances in Artificial Intelligence and Wearable Sensors in Healthcare Delivery
Junaid, S. B., Imam, A. A., Abdulkarim, M., Surakat, Y. A., Balogun, A. O., Kumar, G., Shuaibu, A. N., Garba, A., Sahalu, Y., Mohammed, A., et al. (2022) · Applied Sciences · doi:10.3390/app122010271 · Cited by 65
“REVIEW The assessment of transdermal glucose is likely the most widely engaged wearable sensor to regularly monitor the state of a severe condition (diabetes) [47,48].”
BackgroundCappon, G., Vettoretti, M., Marturano, F., Facchinetti, A., & Sparacino, G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818759558 · Cited by 62
Self-citationWearable Healthcare and Continuous Vital Sign Monitoring with IoT Integration
Taherdoost, H. (2024) · Computers, Materials & Continua · doi:10.32604/cmc.2024.054378 · Cited by 47
Personalized medicine, digital technology and trust: a Kantian account
Myskja, B. K., & Steinsbekk, K. S. (2020) · Medicine, Health Care and Philosophy · doi:10.1007/s11019-020-09974-z · Cited by 37
Lucidi, P., Porcellati, F., Bolli, G. B., & Fanelli, C. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1065-6 · Cited by 38
Valenzano, M., Cibrario Bertolotti, I., Valenzano, A., & Grassi, G. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001045 · Cited by 34
Vahlsing, T., Delbeck, S., Leonhardt, S., & Heise, H. M. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818798347 · Cited by 28
Sarma, A. D., & Devi, M. (2025) · Hormones · doi:10.1007/s42000-025-00644-4 · Cited by 16
Schiavon, M., Acciaroli, G., Vettoretti, M., Giaretta, A., & Visentin, R. (2018) · 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2018.8512257 · Cited by 5
Self-citation
Metadata
- Authors
- Cappon, G., Acciaroli, G., Vettoretti, M., Facchinetti, A., & Sparacino, G.
- Venue
- Electronics
- Publisher
- MDPI AG
- Published
- 2017-09-05
- Volume
- 6
- Issue
- 3
- Pages
- 65
- ISSN
- 2079-9292 (ISSN-L)
- OpenAlex
- W2750794793
- Cited by
- 237
- References
- 22
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.